...

首页> 外文期刊>Journal of Clinical Medicine Research >Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy

【24h】

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy

机译：在葡萄糖Cotroanger-2抑制剂治疗期间增加血细胞比容

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Medicine Research》 |2017年第2期|共2页
作者
Samuel N. Heyman; Mogher Khamaisi; Christian Rosenberger; Auryan Szalat; Zaid Abassi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)" [J] . Taegtmeyer Heinrich, Karlstaedt Anja Circulation: An Official Journal of the American Heart Association . 2018,第9期

机译：Taegtmeyer和Karlstaedt关于文章的信，“在钠 - 葡萄糖Cotoransporter-2抑制剂与其他葡萄糖降低药物中发起的患者的患者风险和死亡风险：CVD-Real研究（钠新用户的心血管结果的比较有效性 -Glucose COTRANSPORTER-2抑制剂）“
2. Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)" [J] . Kosiborod Mikhail, Cavender Matthew A., Fu Alex Z., Circulation: An Official Journal of the American Heart Association . 2018,第9期

机译：Kosiborod等人对文章的回应，“在钠 - 葡萄糖Cot转储-2抑制剂与其他葡萄糖降低药物上发起的患者的心力衰竭和死亡风险降低：CVD-Real研究（新用户心血管结果的比较有效性葡萄糖Cotroansporter-2抑制剂）“
3. Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)" [J] . He Jin-shan, Li Xue-bin Circulation: An Official Journal of the American Heart Association . 2018,第9期

机译：金山和薛斌关于文章的信，“在钠 - 葡萄糖基础抑制剂-2抑制剂上发起的患者的心力衰竭和死亡风险降低：CVD-REAL研究（心血管成果的比较有效性钠葡萄糖COTRANSPORTER-2抑制剂的新用户）“
4. Combination of angiogenesis inhibitors increases the anti-tumor efficacy of photodynamic therapy in a human bladder tumor xenograft model [C] . Ramaswamy Bhuvaneswari, Yik Yuen Gan, Patricia SP Thong, World congress of the International Photodynamic Association . 2009

机译：血管生成抑制剂的组合增加了光动力疗法在人膀胱肿瘤异种移植模型中的抗肿瘤功效
5. The effect of photodynamic therapy (PDT) on epidermal growth factor receptor and interleukin-6 cytokine signaling, and tyrosine kinase inhibitors enhance the efficacy of PDT by increasing intracellular accumulation of photosensitizers. [D] . Liu, Weiguo. 2005

机译：光动力疗法（PDT）对表皮生长因子受体和白介素6细胞因子信号转导的影响，酪氨酸激酶抑制剂通过增加光敏剂在细胞内的积累来增强PDT的功效。
6. Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy [O] . Samuel N. Heyman, Mogher Khamaisi, Christian Rosenberger, 2017

机译：钠葡萄糖共转运蛋白2抑制剂治疗期间血细胞比容增加
7. Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy [O] . Samuel N. Heyman, Mogher Khamaisi, Christian Rosenberger, 2017

机译：在葡萄糖Cotroanger-2抑制剂治疗期间增加血细胞比容

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号